BAM
TEVA icon

Brave Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Brave Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,817
Closed -$490K – 158
2020
Q4 		$490K Hold
50,817
– – 0.19% 63
2020
Q3 		$458K Buy
+50,817
New +$538K 0.22% 57
2020
Q1 		– Sell
-4,317
Closed -$42K – 156
2019
Q4 		$42K Buy
+4,317
New +$38.5K 0.02% 152
2019
Q3 		– Sell
-14,852
Closed -$137K – 161
2019
Q2 		$137K Buy
+14,852
New +$179K 0.08% 131
2016
Q4 		– Sell
-4,917
Closed -$226K – 311
2016
Q3 		$226K Sell
4,917
-3,750
-43% -$196K 0.14% 117
2016
Q2 		$435K Buy
8,667
+2,925
+51% +$156K 0.29% 79
2016
Q1 		$307K Hold
5,742
– – 0.22% 99
2015
Q4 		$377K Sell
5,742
-1,200
-17% -$74.2K 0.25% 92
2015
Q3 		$392K Sell
6,942
-550
-7% -$35.7K 0.3% 85
2015
Q2 		$443K Hold
7,492
– – 0.31% 86
2015
Q1 		$467K Hold
7,492
– – 0.33% 79
2014
Q4 		$431K Buy
7,492
+242
+3% +$13.5K 0.31% 85
2014
Q3 		$390K Sell
7,250
-400
-5% -$21.2K 0.29% 92
2014
Q2 		$401K Hold
7,650
– – 0.28% 99
2014
Q1 		$404K Sell
7,650
-300
-4% -$13.9K 0.32% 86
2013
Q4 		$319K Buy
+7,950
New +$313K 0.26% 93

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Brave Asset Management's TEVA Position: Q1 2021 in Review

Brave Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2021, closing a stake of 50,817 shares — an estimated $490K sold.

Brave Asset Management first reported a position in TEVA in Q4 2013 and held it in 16 quarters. The position peaked at $490K in Q4 2020. 451 funds tracked by Wall St. Rank hold TEVA as of Q1 2021.

  • Brave Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2021 after selling out during the quarter.
  • Brave Asset Management sold 50,817 Teva Pharmaceutical Industries Limited shares in Q1 2021, an estimated $490K.
  • Brave Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 16 quarters.
  • Brave Asset Management's Teva Pharmaceutical Industries Limited position peaked at $490K in Q4 2020.
  • 451 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2021.

Based on Brave Asset Management's 13F filing for Q1 2021, filed 26 Apr 2021.